- Home
- CVLG vs CVAC Comparison
CVLG vs CVAC Comparison
Compare CVLG & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVLG
- CVAC
- Stock Information
- Founded
- CVLG 1986
- CVAC 2000
- Country
- CVLG United States
- CVAC Germany
- Employees
- CVLG N/A
- CVAC N/A
- Industry
- CVLG Trucking Freight/Courier Services
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- CVLG Industrials
- CVAC Health Care
- Exchange
- CVLG Nasdaq
- CVAC Nasdaq
- Market Cap
- CVLG 683.3M
- CVAC 1.2B
- IPO Year
- CVLG 1994
- CVAC 2020
- Fundamental
- Price
- CVLG $24.07
- CVAC $5.46
- Analyst Decision
- CVLG Strong Buy
- CVAC Hold
- Analyst Count
- CVLG 2
- CVAC 3
- Target Price
- CVLG $35.25
- CVAC $6.83
- AVG Volume (30 Days)
- CVLG 142.1K
- CVAC 976.4K
- Earning Date
- CVLG 07-23-2025
- CVAC 08-14-2025
- Dividend Yield
- CVLG 1.17%
- CVAC N/A
- EPS Growth
- CVLG N/A
- CVAC N/A
- EPS
- CVLG 1.39
- CVAC 0.87
- Revenue
- CVLG $1,122,068,000.00
- CVAC $566,039,775.00
- Revenue This Year
- CVLG $2.61
- CVAC N/A
- Revenue Next Year
- CVLG $5.94
- CVAC $24.04
- P/E Ratio
- CVLG $17.21
- CVAC $6.34
- Revenue Growth
- CVLG 0.59
- CVAC 787.60
- 52 Week Low
- CVLG $17.46
- CVAC $2.37
- 52 Week High
- CVLG $30.77
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- CVLG 49.11
- CVAC 61.56
- Support Level
- CVLG $24.11
- CVAC $5.42
- Resistance Level
- CVLG $26.35
- CVAC $5.49
- Average True Range (ATR)
- CVLG 0.74
- CVAC 0.07
- MACD
- CVLG -0.15
- CVAC -0.06
- Stochastic Oscillator
- CVLG 17.65
- CVAC 47.22
About CVLG Covenant Logistics Group Inc.
Covenant Logistics Group Inc together with its wholly-owned subsidiaries offers truckload transportation and freight brokerage services to customers throughout the continental United States. The company's reportable segments include Expedited, Dedicated Services, Managed Freight and Warehousing. Expedited segment provides truckload services to customers with high service freight and delivery standards. Dedicated segment provides customers with committed truckload capacity over contracted periods with the goal of three to five years in length. Managed Freight segment includes brokerage services and TMS. Warehousing segment provides day-to-day warehouse management services to customers who have chosen to outsource this function. Majority of revenue is generated from expedited segment.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.